← Scroll for more →
Organon & Co. (OGN)
Pharmaceutical Preparations
Latest Price
$13.70
TTM P/E
17.56
Normalized P/E
4.87
Div Yield
0.58%
Book Value
3.83
P/B Ratio
3.58
Valuation metrics
adjust assumptions →EPS: $0.72
Book value / share: $2.89
Formula: √(22.5 × EPS × BVPS)
Graham Number
$6.84
50% downside
Norm. op. income: $1.3B (median of 5yr)
Tax rate: 18%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$10.60
23% downside
EPS: $0.72
Target P/E: 5×
Formula: EPS × P/E
P/E Fair Value
$3.60
74% downside
Institutional Ownership
77.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 32.06M | $434.0M | 12.21% | +339.8K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 15.13M | $204.0M | 5.76% | -6.71M | 2026-06-30 |
| Vanguard Capital Management LLC | 11.91M | $161.0M | 4.54% | +172.8K | 2026-06-30 |
| State Street Corp | 9.66M | $130.0M | 3.68% | -297.4K | 2026-06-30 |
| Kahn Brothers Group Inc | 5.54M | $33.0M | 2.11% | -- | 2026-06-30 |
| Goldman Sachs Group Inc | 5.20M | $70.0M | 1.98% | +3.59M | 2026-06-30 |
| UBS Group AG | 4.86M | $65.0M | 1.85% | +1.38M | 2026-06-30 |
| Geode Capital Management, LLC | 4.82M | $65.0M | 1.83% | +56.3K | 2026-06-30 |
| Alliancebernstein L.P. | 4.75M | $28.0M | 1.81% | +4.03M | 2026-06-30 |
| Man Group plc | 4.18M | $56.0M | 1.59% | +4.12M | 2026-06-30 |